Sunesis To Present At Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer and President of Sunesis, will present at two upcoming investor conferences;
  • Leerink Global Healthcare Conference Thursday, February 13th at 11:10 AM Eastern Time The Waldorf Astoria, New York City  
  • 2014 RBC Capital Markets' Global Healthcare Conference Tuesday, February 25th at 1:35 PM Eastern Time The New York Palace Hotel, New York City

A live webcast of the presentations will be available on the Sunesis website at A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.

For additional information on Sunesis, please visit
CONTACT: Investor and Media Inquiries:         David Pitts         Argot Partners         212-600-1902                  Eric Bjerkholt         Sunesis Pharmaceuticals Inc.         650-266-3717                  Eliza Schleifstein         Argot Partners         917-763-8106

Sunesis Pharmaceuticals, Inc. Logo